KHTRF - Health Canada to review Knight's NDS for Bijuva November, 26 2019 07:46 AM Knight Therapeutics Inc Knight Therapeutics' (OTC:KHTRF) New Drug Submission (NDS) for BIJUVA has been accepted for review by Health Canada.More news on: Knight Therapeutics Inc., TherapeuticsMD, Inc., Healthcare stocks news, Read more ...